구강 마이크로바이옴 시장 예측(-2034년) : 제품 유형, 기술, 용도, 최종사용자, 유통 채널, 인구통계 및 지역별 세계 분석

According to Stratistics MRC, the Global Oral Microbiome Market is accounted for $1.14 billion in 2026 and is expected to reach $3.71 billion by 2034 growing at a CAGR of 15.9% during the forecast period. The oral microbiome market focuses on understanding and modulating the complex ecosystem of microorganisms residing in the oral cavity to improve dental and systemic health. Scientific advances linking oral bacteria to conditions beyond gum disease including cardiovascular disorders, diabetes, and Alzheimer's are driving innovation in targeted therapeutics and diagnostics. This emerging field encompasses probiotic formulations, diagnostic testing, microbiome-based therapeutics, and specialized oral care products designed to maintain microbial balance.

Market Dynamics:

Driver:

Growing scientific evidence linking oral health to systemic diseases

Accumulating research establishing connections between oral microbiome composition and overall health conditions is expanding market relevance beyond dentistry. Studies demonstrating associations between periodontal pathogens and cardiovascular disease, adverse pregnancy outcomes, and respiratory infections create compelling reasons for consumers and healthcare providers to prioritize oral microbial balance. This broader health context elevates oral care from cosmetic concern to essential wellness practice, driving demand for products supporting beneficial bacterial populations. Healthcare professionals increasingly recommend microbiome-friendly oral care, expanding market reach through professional channels and medical endorsement.

Restraint:

Regulatory complexities in product classification

Uncertain regulatory pathways for oral microbiome products create significant market entry barriers and commercialization challenges. Products modulating microbial populations may face classification as cosmetics, dietary supplements, medical devices, or drugs depending on claims and formulations, each requiring different approval processes. This regulatory ambiguity increases development costs, extends time-to-market, and creates compliance risks for manufacturers. Inconsistent international regulations further complicate global commercialization strategies. Smaller innovators particularly struggle with navigating these complex requirements, potentially limiting product diversity and slowing overall market expansion despite strong scientific foundations and consumer interest.

Opportunity:

Integration of artificial intelligence in microbiome analysis

AI-powered platforms analyzing complex oral microbiome data present transformative opportunities for personalized oral care recommendations. Machine learning algorithms can identify microbial patterns associated with specific disease risks, enabling predictive diagnostics and targeted interventions. These technologies process vast datasets from sequencing and metabolomics to generate actionable insights for consumers and dental professionals. AI integration facilitates development of companion diagnostics for microbiome therapeutics and enables real-time treatment optimization. As computational capabilities advance and costs decrease, AI-driven personalized oral health solutions become accessible to broader populations, creating substantial market expansion opportunities.

Threat:

Skepticism from traditional dental professionals

Resistance from conventional dentistry practitioners threatens market adoption by influencing patient perceptions and treatment recommendations. Many dental professionals remain unfamiliar with microbiome science or skeptical of probiotic approaches to oral health, preferring established mechanical and chemical interventions. This skepticism limits professional endorsements and referrals that significantly influence patient acceptance of novel products. Without dental community support, microbiome products risk being perceived as unsubstantiated wellness trends rather than evidence-based therapeutic options, constraining market penetration and delaying integration into standard oral care protocols and professional recommendations.

Covid-19 Impact:

The COVID-19 pandemic heightened awareness of immune health and its connection to microbial balance, benefiting oral microbiome market interest. Consumers increasingly recognized oral cavity as entry point for pathogens, driving interest in products supporting oral immune defenses. Tele-dentistry expansion during lockdowns familiarized patients with remote oral health management, creating channels for microbiome-based product recommendations. However, pandemic-related disruptions to dental visits reduced professional sampling and recommendation opportunities temporarily. The lasting legacy includes sustained consumer interest in proactive oral health management and acceptance of digital health approaches supporting continued market growth.

The Oral Care Products segment is expected to be the largest during the forecast period

The Oral Care Products segment is expected to account for the largest market share during the forecast period, encompassing toothpastes, mouthwashes, and specialized formulations designed to support beneficial oral bacteria. These products integrate microbiome-friendly ingredients while maintaining traditional cleaning functions, allowing consumers to upgrade existing routines without behavioral changes. Major oral care brands have entered this segment through product line extensions, leveraging established distribution channels and consumer trust. The segment benefits from daily usage patterns and broad demographic appeal, ensuring sustained market leadership as microbiome science integrates into conventional oral care.

The Next-Generation Sequencing (NGS) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Next-Generation Sequencing (NGS) segment is predicted to witness the highest growth rate, enabling comprehensive profiling of oral microbial communities with unprecedented accuracy and depth. NGS technology allows identification of bacterial species and strains associated with health and disease, supporting diagnostic applications and therapeutic development. Decreasing sequencing costs make this technology increasingly accessible for clinical and direct-to-consumer applications. Dental professionals utilize NGS-based testing for personalized treatment planning, while researchers employ these tools for microbiome discoveries. The segment's essential role in advancing both diagnostics and therapeutics drives exceptional growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by advanced dental healthcare infrastructure, high consumer awareness, and significant research investment. The region hosts leading microbiome research institutions and innovative startups commercializing scientific discoveries. Strong direct-to-consumer marketing channels and consumer willingness to adopt novel wellness products accelerate market penetration. Dental insurance coverage for preventive care and professional recommendations for microbiome-based products further drive adoption. Established relationships between researchers, clinicians, and manufacturers create an innovation ecosystem maintaining North America's dominant market position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by large populations, rising dental health awareness, and expanding middle-class access to premium oral care. Countries including China, Japan, and South Korea combine traditional appreciation for preventive health with rapid adoption of advanced wellness technologies. Increasing dental tourism and international exposure familiarize consumers with microbiome concepts. Government initiatives promoting preventive healthcare and rising healthcare expenditure support market infrastructure development. As international microbiome companies expand distribution partnerships and local manufacturers develop regionally relevant products, Asia Pacific emerges as the fastest-growing regional market.

Key players in the market

Some of the key players in Oral Microbiome Market include Colgate-Palmolive Company, Procter & Gamble Company, Johnson & Johnson, GlaxoSmithKline plc, Unilever PLC, 3M Company, Dentsply Sirona Inc., Kao Corporation, Lion Corporation, Sunstar Suisse S.A., Oragenics, Inc., BLIS Technologies Limited, Oral Biotech Ltd., Microbiome Insights Inc., and Viome Life Sciences, Inc.

Key Developments:

In January 2026, Colgate-Palmolive announced a new multi-year global partnership with the WHO Foundation to advance oral health. The initiative focuses on scaling preventive measures and education, recognizing oral diseases as a foundational public health priority linked to overall systemic health.

In July 2025, Haleon broke ground on a new £130 million Global Oral Health Innovation Centre in Weybridge, UK. This facility is dedicated to R&D in dental science, including the study of oral biofilms and their impact on systemic health.

In May 2025, Unilever scientists, in collaboration with the University of Liverpool, published a study in the British Journal of Dermatology regarding the microbiome-brain axis. While focused on skin, the company confirmed this research is being applied to its oral care portfolio (Zendium brand) to understand the link between oral bacteria and psychological wellbeing.

Product Types Covered:

• Probiotic-Based Oral Products
• Prebiotic Oral Products
• Synbiotic Formulations
• Oral Microbiome Diagnostics & Test Kits
• Microbiome-Based Therapeutics
• Oral Care Products
• Dietary Supplements
• Other Product Types

Technologies Covered:

• Next-Generation Sequencing (NGS)
• Metagenomics
• Metatranscriptomics
• Proteomics & Metabolomics
• Bioinformatics & Microbiome Analytics
• AI-Based Microbiome Modeling
• Other Technologies

Applications Covered:

• Dental Caries Prevention
• Periodontal Diseases
• Halitosis Management
• Oral Cancer Detection & Risk Assessment
• Systemic Disease Link
• Personalized Oral Healthcare
• Preventive Dentistry
• Other Applications

End Users Covered:

• Dental Clinics
• Hospitals
• Research & Academic Institutes
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Individual Consumers
• Other End Users

Distribution Channels Covered:

• Online Platforms
• Pharmacies & Drug Stores
• Dental Clinics & Hospitals
• Specialty Stores
• Direct-to-Consumer Channels
• Other Distribution Channels

Demographics Covered:

• Adults
• Pediatrics
• Geriatric Population

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Oral Microbiome Market, By Product Type

• 5.1 Probiotic-Based Oral Products
• 5.2 Prebiotic Oral Products
• 5.3 Synbiotic Formulations
• 5.4 Oral Microbiome Diagnostics & Test Kits
• 5.5 Microbiome-Based Therapeutics
• 5.6 Oral Care Products
• 5.7 Dietary Supplements
• 5.8 Other Product Types

6 Global Oral Microbiome Market, By Technology

• 6.1 Next-Generation Sequencing (NGS)
• 6.2 Metagenomics
• 6.3 Metatranscriptomics
• 6.4 Proteomics & Metabolomics
• 6.5 Bioinformatics & Microbiome Analytics
• 6.6 AI-Based Microbiome Modeling
• 6.7 Other Technologies

7 Global Oral Microbiome Market, By Application

• 7.1 Dental Caries Prevention
• 7.2 Periodontal Diseases
• 7.3 Halitosis Management
• 7.4 Oral Cancer Detection & Risk Assessment
• 7.5 Systemic Disease Link
• 7.6 Personalized Oral Healthcare
• 7.7 Preventive Dentistry
• 7.8 Other Applications

8 Global Oral Microbiome Market, By End User

• 8.1 Dental Clinics
• 8.2 Hospitals
• 8.3 Research & Academic Institutes
• 8.4 Diagnostic Laboratories
• 8.5 Pharmaceutical & Biotechnology Companies
• 8.6 Individual Consumers
• 8.7 Other End Users

9 Global Oral Microbiome Market, By Distribution Channel

• 9.1 Online Platforms
• 9.2 Pharmacies & Drug Stores
• 9.3 Dental Clinics & Hospitals
• 9.4 Specialty Stores
• 9.5 Direct-to-Consumer Channels
• 9.6 Other Distribution Channels

10 Global Oral Microbiome Market, By Demographics

• 10.1 Adults
• 10.2 Pediatrics
• 10.3 Geriatric Population

11 Global Oral Microbiome Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Colgate-Palmolive Company
• 14.2 Procter & Gamble Company
• 14.3 Johnson & Johnson
• 14.4 GlaxoSmithKline plc
• 14.5 Unilever PLC
• 14.6 3M Company
• 14.7 Dentsply Sirona Inc.
• 14.8 Kao Corporation
• 14.9 Lion Corporation
• 14.10 Sunstar Suisse S.A.
• 14.11 Oragenics, Inc.
• 14.12 BLIS Technologies Limited
• 14.13 Oral Biotech Ltd.
• 14.14 Microbiome Insights Inc.
• 14.15 Viome Life Sciences, Inc.